January 30, 2026

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising 105.91% Upside in the Medical Device Sector

Beta Bionics, Inc. (NASDAQ: BBNX) stands out as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Strong Revenue Growth and Attractive Valuation with 17.24% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) stands out in the healthcare sector with its focus on developing and commercializing innovative pain management solutions. Based in Stoughton, Massachusetts,..

Immunome, Inc. (IMNM) Stock Analysis: Unveiling a 37.61% Upside Potential in Promising Cancer Therapies

Investors with an eye on the biotechnology sector have plenty to consider with Immunome, Inc. (NASDAQ: IMNM). This clinical-stage biotech company is making significant strides in..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 348% Upside in the Biotech Sector

For investors seeking opportunities in the dynamic biotech industry, Anavex Life Sciences Corp. (NASDAQ: AVXL) presents an intriguing prospect. With a market capitalization of $438.7 million,..

RxSight, Inc. (RXST) Stock Analysis: A 17.85% Potential Upside in the Healthcare Sector

RxSight, Inc. (RXST), a pioneering firm in the medical devices industry, is captivating investor attention with its innovative solutions in cataract surgery. Headquartered in Aliso Viejo,..

Pharvaris N.V. (PHVS) Stock Analysis: A Biotechnology Gem with 69% Upside Potential

Pharvaris N.V. (PHVS), a promising player in the biotechnology sector, has been capturing the attention of investors with its innovative approach to tackling rare diseases. Based..

Taysha Gene Therapies (TSHA) Stock Analysis: A 140% Upside Beckons Investors Amidst Promising Gene Therapy Advances

Taysha Gene Therapies, Inc. (TSHA) is drawing attention from the investment community with its compelling potential upside of 140.70%. As a clinical-stage biotechnology firm, Taysha is..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unveiling a 41.94% Potential Upside with Robust Buy Ratings

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology firm rooted in the heart of San Diego, California, is turning heads in the healthcare sector. With a market..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a Remarkable 229.75% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC) stands at the forefront of innovation in the biotechnology sector, captivating investor interest with its unique approach to tackling diseases underserved..

Embecta Corp. (EMBC) Stock Analysis: A 61.81% Potential Upside in the Healthcare Sector

Embecta Corp. (NASDAQ: EMBC) is drawing attention in the healthcare sector with its impressive 61.81% potential upside, making it a notable consideration for investors seeking opportunities..

AMN Healthcare Services Inc (AMN): Investor Outlook on Stock Performance and Strategic Positioning

AMN Healthcare Services Inc (NYSE: AMN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

GH Research PLC (GHRS) Stock Analysis: A Biotech Gem with Over 100% Upside Potential

As the biopharmaceutical industry continues to evolve, investors are keenly eyeing companies at the forefront of innovative treatments. GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical..

iRadimed Corporation (IRMD) Stock Analysis: Evaluating the Growth Potential in MRI-Compatible Medical Devices

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the healthcare sector, specializes in creating innovative medical devices compatible with magnetic resonance imaging (MRI). With a market..

Firering targets production uplift at Zambian lime project

AIM-listed Firering moves into production expansion at its Zambian lime plant, strengthening its industrial minerals footprint...

STAAR Surgical Company (STAA) Stock Analysis: Insights into the 23.34% Potential Upside

STAAR Surgical Company (NASDAQ: STAA) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Oculis Holding AG (OCS) Stock Analysis: A Biotech Gem with 63.59% Potential Upside

Investors eyeing the biotechnology sector may want to pay close attention to Oculis Holding AG (OCS), a Swiss company making significant strides in ophthalmic disease treatments...

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 90.91% Potential Upside Sparks Investor Interest

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a biotechnology company based in New York and focused on innovative cancer therapies, is drawing significant attention from the investor community...

Day One Biopharmaceuticals (DAWN) Investor Outlook: Unveiling a Potential 111% Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is making waves in the biotechnology sector with its innovative approach to treating both childhood and adult diseases. As a..

Nutex Health Inc. (NUTX) Stock Analysis: An Astonishing 68% Potential Upside Awaits Investors

Nutex Health Inc. (NUTX) is making waves in the healthcare sector with a remarkable potential upside of 68.32%, according to analyst target prices. With a current..

Immatics N.V. (IMTX) Stock Analysis: Exploring the 103.89% Potential Upside in the Biotechnology Sector

Immatics N.V. (NASDAQ: IMTX), a trailblazer in the biotechnology sector, is capturing the attention of investors with its innovative approach to cancer treatment and a significant..

Search

Funds

January 30, 2026

Firering targets production uplift at Zambian lime project

AIM-listed Firering moves into production expansion at its Zambian lime plant, strengthening its industrial minerals footprint...
Search

Funds

January 30, 2026

FTSE 100

Funds